Safety and Efficacy Study of Absnow Absorbable ASD Closure System For Treating ASD Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 165 participants.
Also called NCT03601039
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 165 participants
- Registry
-
NCT03601039
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT03601039. Allocation not applicable; no masking; primary purpose treatment. Start 2018-08-25 (actual); primary completion 2020-08-28 (actual). Results posted on 2026-03-10.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy Study of Absnow Absorbable ASD Closure System For Treating ASD Patients
- Condition
- Heart Septal Defects, Atrial
- Condition
- Atrial Septal Defect
- Intervention (Device)
- Absnow Absorbable ASD Closure System
- Lead sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
Record details
- Record id
cardio:ct-nct03601039- Content hash
0446be557f79817cdb44f987461f302df8ab3887e95c8a83c47b91f443bd5cfa